Bioceres Crop Solutions (NASDAQ:BIOX) Rating Lowered to Hold at Brookline Capital Management

Key Points

• Bioceres Crop Solutions was downgraded from a "strong-buy" rating to a "hold" rating by Brookline Capital Management, indicating a shift in analyst sentiment regarding the stock.
• Research firms, including Wall Street Zen, have also reduced their ratings, with Oppenheimer lowering the price target from $7.00 to $6.00, reflecting growing concerns over the company's performance.
• The company reported a revenue of $59.60 million for the latest quarter, falling short of the consensus estimate of $61.80 million, which may impact investor confidence moving forward.

Brookline Capital Management lowered shares of Bioceres Crop Solutions (NASDAQ:BIOX - Free Report) from a strong-buy rating to a hold rating in a research note issued to investors on Thursday, August 21st,Zacks.com reports.

A number of other brokerages have also weighed in on BIOX. Wall Street Zen lowered shares of Bioceres Crop Solutions from a "hold" rating to a "sell" rating in a research note on Saturday, August 23rd. Oppenheimer reduced their target price on shares of Bioceres Crop Solutions from $7.00 to $6.00 and set an "outperform" rating for the company in a research note on Tuesday, July 15th. Four equities research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average target price of $8.38.

Bioceres Crop Solutions Stock Down 0.6%

NASDAQ BIOX traded down $0.02 on Thursday, reaching $2.69. The company had a trading volume of 187,130 shares, compared to its average volume of 209,742. The firm has a market capitalization of $168.38 million, a price-to-earnings ratio of -19.18, a price-to-earnings-growth ratio of 1.20 and a beta of 0.44. The company has a debt-to-equity ratio of 0.22, a quick ratio of 0.74 and a current ratio of 1.02. Bioceres Crop Solutions has a 1-year low of $2.60 and a 1-year high of $11.39. The company's fifty day moving average is $3.76 and its 200-day moving average is $4.27.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of BIOX. Bank of America Corp DE grew its stake in Bioceres Crop Solutions by 186.8% in the 4th quarter. Bank of America Corp DE now owns 5,735 shares of the company's stock valued at $35,000 after buying an additional 3,735 shares during the last quarter. Jones Financial Companies Lllp grew its stake in Bioceres Crop Solutions by 3,535.8% in the 1st quarter. Jones Financial Companies Lllp now owns 5,490 shares of the company's stock valued at $25,000 after buying an additional 5,339 shares during the last quarter. Avanza Fonder AB grew its stake in Bioceres Crop Solutions by 62.9% in the 2nd quarter. Avanza Fonder AB now owns 26,164 shares of the company's stock valued at $117,000 after buying an additional 10,099 shares during the last quarter. PDT Partners LLC grew its stake in Bioceres Crop Solutions by 58.9% in the 2nd quarter. PDT Partners LLC now owns 28,180 shares of the company's stock valued at $126,000 after buying an additional 10,449 shares during the last quarter. Finally, Jump Financial LLC acquired a new position in Bioceres Crop Solutions in the 4th quarter valued at about $72,000. 17.68% of the stock is currently owned by institutional investors and hedge funds.

About Bioceres Crop Solutions

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.